Ban Abortion by Mail Act prohibits REMS-certified providers from prescribing abortion drugs without an in-person visit and a state license.

The Ban Abortion by Mail Act mandates that REMS-certified providers must conduct an in-person visit with patients before prescribing or administering abortion drugs, such as mifepristone. Providers who violate this requirement by prescribing these drugs without an in-person visit or without a medical license in the patient's state will lose their REMS-certified status for at least two years. The Secretary of Health and Human Services is required to report annually to Congress on any REMS-certified providers who lose their status due to violations of this act.

Ban Abortion by Mail Act prohibits REMS-certified providers from prescribing abortion drugs without an in-person visit and a state license.

The Ban Abortion by Mail Act mandates that REMS-certified providers must conduct an in-person visit with patients before prescribing or administering abortion drugs, such as mifepristone. Providers who violate this requirement by prescribing these drugs without an in-person visit or without a medical license in the patient's state will lose their REMS-certified status for at least two years. The Secretary of Health and Human Services is required to report annually to Congress on any REMS-certified providers who lose their status due to violations of this act.